Shares of Protalix Biotherapeutics Inc (NYSEAMERICAN:PLX) saw strong trading volume on Wednesday . 3,171,206 shares changed hands during mid-day trading, an increase of 375% from the previous session’s volume of 667,423 shares.The stock last traded at $0.62 and had previously closed at $0.52.
Several equities research analysts recently commented on the company. HC Wainwright set a $4.00 price target on Protalix Biotherapeutics and gave the company a “buy” rating in a research note on Monday, August 13th. Zacks Investment Research raised Protalix Biotherapeutics from....More>>>